brl 42810 has been researched along with Sensitivity and Specificity in 4 studies
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gouda, AA | 1 |
| Shafey, ZE | 1 |
| Hossny, N | 1 |
| El-Azzazy, R | 1 |
| Diaz-Mitoma, F | 1 |
| Ruben, M | 1 |
| Sacks, S | 1 |
| MacPherson, P | 1 |
| Caissie, G | 1 |
| Atkins, CD | 1 |
| Lewin, SR | 1 |
| Ribeiro, RM | 1 |
| Walters, T | 1 |
| Lau, GK | 1 |
| Bowden, S | 1 |
| Locarnini, S | 1 |
| Perelson, AS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Study of Pharmacokinetics, Clinical and Virologic Response to Acyclovir Episodic Therapy for Genital Herpes Ulcers in HIV Negative African Women[NCT02053142] | 74 participants (Actual) | Interventional | 2009-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for brl 42810 and Sensitivity and Specificity
| Article | Year |
|---|---|
Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Herpes Genitalis; Humans; Polymerase Chain | 1996 |
3 other studies available for brl 42810 and Sensitivity and Specificity
| Article | Year |
|---|---|
Spectrophotometric determination of hyoscine butylbromide and famciclovir in pure form and in pharmaceutical formulations.
Topics: 2-Aminopurine; Butylscopolammonium Bromide; Chemistry, Pharmaceutical; Famciclovir; Hydrogen-Ion Con | 2008 |
Translating statistics for use in the clinic.
Topics: 2-Aminopurine; Antiviral Agents; Breast Neoplasms; Clinical Trials as Topic; Data Interpretation, St | 1997 |
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.
Topics: 2-Aminopurine; Antiviral Agents; Computer Systems; DNA, Viral; Drug Therapy, Combination; Famciclovi | 2001 |